24小时热门版块排行榜    

查看: 1290  |  回复: 9
本帖产生 1 个 翻译EPI ,点击这里进行查看
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

AnnF

版主 (文坛精英)

[求助] 大神们,真心求助!有200BB相赠!!!

Within the limits of experimental error, the title compounds withD-confi guration displayed better antitumor activities against Bcap37 compared to their respective L -counterparts e.g. D-II a(52.3%) > L- II a (16.9%),D-II e (70.2%)> L-II e (25.9%), D-IIi (34.0%) >L-II i (26.1%). Furthermore, the compound bearing a fl uorine atom at the 4-position of the benzyl ring linked to the nitrogen atom of theamide (R1= p -F) showed good antitumor activities with inhibition rate ranging from 55.7 to 89.1% against BGC823 cell lines. With regard to the alkyl substituents (R2) in the phosphonate part of the studied compounds, D-diastereoisomers with diethyl substituents
(R2 =Et) displayed signi fi cant enhancement towards inhibition against Bcap37, PC3 and BGC823 cells in comparison with D- O,O-dialkylphosphonates derived from n-propyl, isopropyl or n–butyl groups. In particular, the compound D-IIe(R1 =o -F, R2 = Et) dis-played most promising result amongst all. The L –diastereoisomers of O,O-diisopropylphosphonate e.g. L -II k(R1 = p-F, R2 = i-Pr), L -IIc(R1 = H, R2=i-Pr), L -II g(R1=o-F, R2=i-Pr), on the other hand,revealed higher antitumor activities than the L-diastereoisomers of phosphonates derived from ethyl,n -propyl or butyl groups (R2= Et, n-Pr, Bu). Thus, the nature of stereochemical con fi guration (D or L ) of the amino acid amide part, type of substituents (R1) in the aromatic ring as well as alkyl substituents (R2) in the phosphonate moiety of the title compounds appear to be the key factors in controlling the antitumor activity. While phosphonates derived from branched alkyl chains were preferred over straight-chain alkyls forL-diastereoisomers, simple diethyl derived phosphonates gave better result with D-diastereoisomers. Therefore, for ideal activity, R1should be a strong electron withdrawing group and for L-diastereoisomers R2 should be i-Pr, whereas for D -diastereoiso-mers R2 needs to be Et. Although our studies indicate the existence of a definite relationship of antitumor activity with the nature of substituents and type of confi guration within the compound, the role of steric, electronic and hydrophobic effects at physiological pH on structureeactivity relationships could not be successfully ascertained due to lack of structural diversity.



已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

AnnF

版主 (文坛精英)

引用回帖:
6楼: Originally posted by 淘气宝贝may at 2013-01-13 13:39:33
在实验误差范围内,标题化合物withd-confi形状显示更好的抗肿瘤活性的bcap37比较各自的我-同行如四-二一(52.3%)>我-Ⅱ(16.9%),四-二电子(70.2%)> l-ii电子(25.9%),d-iii(34%)> l-ii我(26.1%) ...

老弟,用点心,行不?
7楼2013-01-13 21:13:35
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 10 个回答

光树林

木虫 (著名写手)

【答案】应助回帖

额,比较专业。。。帮顶吧
一路向北
2楼2013-01-11 17:24:08
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

yunzhongfan2004

金虫 (正式写手)

【答案】应助回帖


爱与雨下: 金币+1 2013-01-11 22:23:04
在实验误差的范围内,D构型的化合物比他们的L构型在抗肿瘤活性方面更有效,例如D-IIa(52.3%)> L-IIa(16.9%),D-IIe(70.2%)> L-IIe(25.9%),D-IIi(34.0%)> L-IIi(26.1 %)。译了一节,有事,明天再说。
4楼2013-01-11 21:58:17
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

scorpionleo

新虫 (初入文坛)

【答案】应助回帖

★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ...
AnnF: 金币+20, 翻译EPI+1, 有帮助, 先收下了,谢谢! 2013-01-13 10:03:05
phu_grassman: 金币+4, thanks 2013-01-19 12:15:09
sltmac: 金币+50 2013-03-10 10:03:45
sltmac: 金币+50, 翻译的很好 2013-03-10 10:03:53
此外,  酰胺(R1= p -F) 氮原子上苯环的4位上具有氟原子的化合物具有良好的抗肿瘤活性, 其对BGC823肿瘤细胞株的抑制率在55.7%到89.1%之间. 关于所研究化合物磷酸酯部分的烷基取代基(R2),二乙基取代(R2 =Et) 得到的D构型的非对映异构体相比由正丙基,异丙基和正丁基取代得到的二烷基磷酸酯, 能更显著地抑制Bcap37, PC3 和BGC823肿瘤细胞株. 尤其是化合物D-IIe(R1 =o -F, R2 = Et)最有潜力. 另一方面,L构型的二异丙基磷酸酯, 如L -II k(R1 = p-F, R2 = i-Pr), L -IIc(R1 = H, R2=i-Pr), L -II g(R1=o-F, R2=i-Pr), 比由乙基,正丙基或正丁基取代生成的磷酸酯具有更高的抗肿瘤活性. 因此,化合物氨基酸酰胺部分的立体化学构象(D 或 L), 芳香环上取代基的类型(R1)以及磷酸酯基团的烷基取代基种类(R2)都是控制其抗肿瘤活性的关键因素. 尽管对于L构型的非对映异构体,支链烷基衍生的磷酸酯比直链烷基的衍生物更具优势,但是在D构型时,简单的二乙基取代得到的结果更佳. 因此,要得到理想的抗肿瘤活性,R1必须是一个强吸电子基团,R2在L构型时应该是异丙基,而在D构型时应该是乙基. 尽管本研究表明化合物取代基的化学本质和构型与其抗肿瘤活性之间存在确定的关系, 然而由于所研究的结构多样性不足, 空间位阻, 电子和疏水作用在生理PH条件下在构效关系中所起的作用尚无法(成功)确定.

I hope the above translaton helps.
5楼2013-01-12 09:44:55
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[找工作] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +4 h4CP7TrQR8Lg 2026-08-22 4/200 2026-08-23 20:55 by 0p9y1isJp2jM
[基金申请] 让我中一个面上吧! +12 大萍1987 2026-08-20 15/750 2026-08-23 20:44 by 大萍1987
[基金申请] 2026年的国家社科基金项目通讯评审的新规则与新动向、新挑战 +4 process2012 2026-08-23 5/250 2026-08-23 19:58 by jurkat.1640
[公派出国] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +3 2JOx3r2CYEgw 2026-08-22 4/200 2026-08-23 19:34 by lXgU0RvNTDC9
[博后之家] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +4 2JOx3r2CYEgw 2026-08-22 6/300 2026-08-23 19:34 by lXgU0RvNTDC9
[公派出国] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +3 2JOx3r2CYEgw 2026-08-22 4/200 2026-08-23 19:22 by lXgU0RvNTDC9
[找工作] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +3 2JOx3r2CYEgw 2026-08-21 5/250 2026-08-23 19:10 by lXgU0RvNTDC9
[考研] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +3 2JOx3r2CYEgw 2026-08-21 5/250 2026-08-23 18:55 by lXgU0RvNTDC9
[论文投稿] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 DpSrDtM079iu 2026-08-22 3/150 2026-08-23 15:33 by KM5EcsNQRBPn
[硕博家园] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +3 2JOx3r2CYEgw 2026-08-21 6/300 2026-08-23 14:21 by KM5EcsNQRBPn
[基金申请] 2026国自然函评费到账 +15 羊腰板 2026-08-21 16/800 2026-08-23 10:45 by process2012
[考博] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +3 2JOx3r2CYEgw 2026-08-21 10/500 2026-08-23 07:17 by OEbVnUOu01ol
[论文投稿] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +3 2JOx3r2CYEgw 2026-08-22 5/250 2026-08-23 03:52 by OEbVnUOu01ol
[考博] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 DpSrDtM079iu 2026-08-22 3/150 2026-08-23 00:55 by OEbVnUOu01ol
[基金申请] 时间戳今天,20号变了 +5 archvillain 2026-08-20 5/250 2026-08-22 06:12 by hui_daxiao
[基金申请] 今日不放榜?网传国自然预计 8 月 27 日可查结果 +16 医学老男孩 2026-08-20 20/1000 2026-08-21 21:13 by Ldrop2023
[基金申请] 感觉是下周放榜了 +7 angus9576 2026-08-17 12/600 2026-08-21 13:38 by weiyin
[基金申请] 我面上完蛋了 +7 且听虎啸 2026-08-20 8/400 2026-08-21 12:31 by 酷酷墨镜
[论文投稿] 投稿咨询 +5 wwm09 2026-08-17 7/350 2026-08-21 10:11 by 期刊论文帮手
[基金申请] 时间戳变了,能看出什么问题? +18 基诺咪客 2026-08-17 23/1150 2026-08-20 17:19 by Godzela
信息提示
请填处理意见